Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024Marine Maurel, Iván Martínez‐Baz, Ivan Mlinarić et al.|Eurosurveillance|2024Cited by 50
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre studyEsther Kissling, Francisco Pozo, Iván Martínez‐Baz et al.|Influenza and Other Respiratory Viruses|2022Cited by 45
Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre studyMarine Maurel, Francisco Pozo, Gloria Pérez‐Gimeno et al.|Influenza and Other Respiratory Viruses|2024Cited by 28
Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24Esther Kissling, Marine Maurel, Francisco Pozo et al.|Eurosurveillance|2025Cited by 9
Influenza vaccine effectiveness against influenza A subtypes in Europe: results from the 2021–22 I-MOVE primary care multicentre studyEsther Kissling, Marta Valenciano, Francisco Pozo et al.|Unknown|2022Cited by 1